STUGERON 25MG TABLETS

Χώρα: Κύπρος

Γλώσσα: Ελληνικά

Πηγή: Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

Δραστική ουσία:

CINNARIZINE

Διαθέσιμο από:

JANSSEN-CILAG INTERNATIONAL NV (0000003494) TURNHOUTSEWEG 30, BEERSE, B-2340

Φαρμακολογική κατηγορία (ATC):

N07CA02

INN (Διεθνής Όνομα):

CINNARIZINE

Δοσολογία:

25MG

Φαρμακοτεχνική μορφή:

TABLETS

Σύνθεση:

CINNARIZINE (0000298577) 25MG

Οδός χορήγησης:

ORAL USE

Τρόπος διάθεσης:

Εθνική Διαδικασία

Θεραπευτική περιοχή:

CINNARIZINE

Περίληψη προϊόντος:

Νομικό καθεστώς: Με Ιατρική Συνταγή που Επαναλαμβάνεται; PACK WITH 50 TABS IN BLISTER(S) (720001301) 50 TABLET - Εγκεκριμένο - Με Ιατρική Συνταγή που Επαναλαμβάνεται

Φύλλο οδηγιών χρήσης

STUGERON 25MG TABLETS
Cinnarizine
INFORMATION FOR PEOPLE TAKING
STUGERON
Before you start to take your medicine, please read this leaflet
carefully all
the
way through as it contains important information. If there is anything
that you
do
not understand or if you need further information or advice, you
should ask
your
pharmacist or doctor who will have more
details.
This leaflet applies only to Stugeron tablets. PLEASE DO NOT THROW IT
AWAY
AS
YOU MAY NEED TO REFER TO IT
AGAIN.
WHAT IS YOUR
MEDICINE?
The active ingredient of Stugeron tablets is
cinnarizine.
Stugeron comes in the form of white tablets marked ‘JANSSEN’ on
one side
and
‘S/25’ on the reverse and is supplied to the pharmacist in packs
containing
50
tablets.
Each tablet contains 25mg of cinnarizine. Stugeron tablets also
contain
lactose*,
maize starch, sucrose*, talc, cottonseed oil – hydrogenated and
polyvidone
as
inactive
ingredients.
*If you have been told by your doctor that you have intolerance to
some
sugars,
contact your doctor before taking this
medicine.
Stugeron is one of a group of medicines known as calcium channel
blockers
which works by preventing the narrowing of blood
vessels.
The product authorisation for this medicine is held by Janssen-Cilag
International
N.V., Turnhoutseweg 30, B-2340 Beerse, Belgium.
Stugeron tablets
are
manufactured by Lusomedicamenta Farmacêutica, SA
Queluz, Portugal
for
Janssen Pharmaceutica N.V., Turnhoutseweg 30, B-2340
Beerse,
Belgium.
WHAT IS YOUR MEDICINE USED
FOR?
Stugeron is usually used for one of the following
conditions:

Maintenance therapy for symptoms of labyrinthine disorders,
including
vertigo, dizziness, tinnitus, nystagmus, nausea and
vomiting.
Prophylaxis
of motion
sickness

Prophylaxis of
migraine

Maintenance therapy for symptoms of cerebrovascular origin,
including
dizziness, ear buzzing (tinnitus), vascular headache, unsociability
and
irritability disorders, loss of memory and lack of
concentration
Maintenance therapy for trophic and varicose ulcers,
paraesthesia,
nocturn